abagovomab 45
abciximab 33
abituzumab 34
abrilumab 23
actoxumab 28
adalimumab 15
aducanumab 18
afasevikumab 16
alacizumab_pegol 9
alemtuzumab 39
alirocumab 19
amatuximab 53
andecaliximab 33
anifrolumab 25
anrukinzumab 19
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 21
ascrinvacumab 20
atezolizumab 14
atinumab 21
avelumab 16
basiliximab 48
bavituximab 43
begelomab 41
benralizumab 32
bevacizumab_beta 22
bezlotoxumab 28
bimagrumab 23
bleselumab 30
blinatumomab 48
blosozumab 41
bococizumab 31
brazikumab 20
brentuximab_vedotin 38
briakinumab 21
brodalumab 29
brolucizumab 30
brontictuzumab 37
burosumab 34
cabiralizumab 37
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 49
carlumab 28
carotuximab 19
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 27
cetiximab 44
citatuzumab_bogatox 32
cixutumumab 45
clivatuzumab_tetraxetan 28
codrituzumab 26
conatumumab 25
concizumab 21
crenezumab 20
crizanlizumab 33
crotedumab 25
dacetuzumab 24
daclizumab 24
dalotuzumab 39
dapirolizumab_pegol 26
daratumumab 16
dectrekumab 15
demcizumab 37
denosumab 8
depatuxizumab 32
depatuxizumab_mafodotin 32
dezamizumab 32
dinutuximab 45
diridavumab 32
domagrozumab 18
drozitumab 21
duligotuzumab 20
durvalumab 17
dusigitumab 35
efalizumab 37
efungumab 26
eldelumab 20
elezanumab 32
elgemtumab 10
elotuzumab 21
emactuzumab 36
emapalumab 28
emibetuzumab 32
enavatuzumab 27
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 35
enoticumab 27
ensituximab 41
eptinezumab 16
erenumab 29
etaracizumab 17
etrolizumab 24
evinacumab 23
evolocumab 34
farletuzumab 6
fasinumab 30
fezakinumab 34
fibatuzumab 28
ficlatuzumab 37
firivumab 36
flanvotumab 28
fletikumab 41
foralumab 19
foravirumab 18
fremanezumab 32
fresolimumab 26
fulranumab 23
futuximab 32
galcanezumab 26
ganitumab 31
gantenerumab 16
gemetuzumab 36
gemtuzumab2 35
gemtuzumab 34
gevokizumab 33
girentuximab 35
glembatumumab 31
glembatumumab_vedotin 31
guselkumab 28
ibalizumab 37
ibritumomab 44
icrucumab 16
idarucizumab 38
ifabotuzumab 28
imalumab 15
imgatuzumab 32
inclacumab 26
indatuximab_ravtansin 35
indusatumab 30
inebilizumab 30
intetumumab 20
iodine_girentuximab 33
ipilimumab 5
iratumumab 25
isatuximab 45
itolizumab 30
ixekizumab 36
labetuzumab_govitecan 27
lambrolizumab 40
lampalizumab 28
lanadelumab 21
landogrozumab 19
laprituximab 37
lebrikizumab 38
lendalizumab 37
lenzilumab 30
lifastuzumab_vedotin 26
ligelizumab 35
lilotomab 41
lirilumab 38
lodelcizumab 32
lokivetmab 18
lorvotuzumab_mertansin 19
lucatumumab 33
lumretuzumab 31
lupartumab 20
lutikizumab 17
margetuximab 40
milatuzumab 32
mirvetuximab 46
mirvetuximab_soravtansin 46
modotuximab 54
mogamulizumab 23
monalizumab 35
motavizumab 36
moxetumomab_pasudotox 19
namilumab 35
naratuximab 43
naratuximab_emtansin 43
narnatumab 22
navicixizumab2 31
navicixizumab 38
navivumab 44
necitumumab 27
nemolizumab 35
nesvacumab 14
nivolumab 21
obiltoxaximab 23
obinutuzumab 37
ocaratuzumab 34
ofatumumab 18
olaratumab 38
olokizumab 25
omalizumab 23
onartuzumab 24
ontuxizumab 34
opicinumab 16
orticumab 15
otelixizumab 40
oxelumab 12
ozanezumab 32
pamrevlumab 13
panobacumab 20
parsatuzumab 34
pasotuxizumab 19
pateclizumab 23
patritumab 33
pembrolizumab 40
perakizumab 24
pidilizumab 17
pinatuzumab_vedotin 21
plozalizumab 23
pogalizumab 36
polatuzumab_vedotin 23
ponezumab 39
prezalumab 15
pritoxaximab 51
quilizumab 20
racotumomab 37
radretumab 19
ralpancizumab 35
ramucirumab 16
ranevetmab 29
ranibizumab 21
refanezumab 28
remtolumab 19
rilotumumab 31
rinucumab 28
risankizumab 39
rituximab 35
rivabazumab 25
robatumumab 22
roledumab 30
romosozumab 34
rontalizumab 27
rosmantuzumab 34
rozanolixizumab 22
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 37
sapelizumab 30
sarilumab 18
secukinumab 24
seribantumab 19
setoxaximab 46
sifalimumab 23
siltuximab 26
simtuzumab 38
sirukumab 14
solanezumab 28
solitomab 33
stamulumab 35
suptavumab 31
suvizumab 22
tabalumab 32
tadocizumab 23
tamtuvetmab 32
tanezumab 33
tarextumab 14
tavolixizumab 25
telisotuzumab 43
teplizumab 21
tesidolumab 36
tezepelumab 30
tigatuzumab 16
tildrakizumab 32
timolumab 18
tisotumab 14
tosatoxumab 40
tositumomab 41
tralokinumab 44
trastuzumab 26
tregalizumab 24
trevogrumab 13
ublituximab 38
urelumab 32
ustekinumab 30
utomilumab 35
vadastuximab 37
vadastuximab_talirin 37
vandortuzumab_vedotin 23
vantictumab 29
vanucizumab2 22
vanucizumab 51
varlilumab 19
vatelizumab 37
vedolizumab 37
veltuzumab 27
vesencumab 15
vorsetuzumab 37
vorsetuzumab_mafodotin 37
vunakizumab 40
xentuzumab 20
zatuximab 54
